Log In
BCIQ
Print this Print this
 

IAB2M

  Manage Alerts
Collapse Summary General Information
Company ImaginAb Inc.
DescriptionRadiolabeled mAb fragment targeting prostate-specific membrane antigen (PSMA; FOLH1; GCPII)
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationCancer, Diagnostic
Indication DetailsDetect metastatic prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today